What is Entero Therapeutics Inc (ENTO)?

Entero Therapeutics Inc (ENTO) Stock Analysis

$2.990

+0.158 (+5.28%)At close

Loading chart…

High: 3.750
Open: 3.170
VWAP: 3.19
Vol: 896.84K
Mkt Cap: —
Low: 2.840
Amount: 2.86M
EV/EBITDA, TTM: 0.00

GridAI Technologies Corp., formerly Entero Therapeutics, Inc., offers a grid-edge, artificial intelligence (AI)-driven software and control platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources, including battery energy storage systems. It applies real-time AI scheduling and optimization to orchestrate devices, fleets, and grid-scale assets. The Company also focuses on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company's programs address significant unmet needs in GI health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

enterothera.com

Valuation Metrics

The current forward P/E ratio for Entero Therapeutics Inc (ENTO) is -0.27, compared to its 5-year average forward P/E of -3.68.

Forward P/E

Fair

5Y Average P/E

-3.68

Current P/E

-0.27

Overvalued

6.66

Undervalued

-14.01

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

0.09

Current P/S

0.00

Overvalued

0.49

Undervalued

-0.30

Alphio AI Price Scenarios for ENTO

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%ENTO

$0.57

Scenario price

Base

Base · 50%ENTO

$0.52

Scenario price

Bear

Bear · 25%ENTO

$0.49

Scenario price

Events Timeline

2025-11-28 (ET)